← All candidates
One insider buy in the last year — $78.5K in all.
250 filings on record.
GHGuardant Health, Inc.
NasdaqGS · Healthcare · $23.47B
$174.90
-0.43% · Sep 16
One insider buy in the last year — $78.5K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 93 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$23.47B
Float
129.5M
96% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
19.8
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chief Information Officer
Kalia Kumud
Bought $78.5K on Jun 15 — 600 sh @ $130.76, held direct, 1.4% of their stake.
No completed positions to measure
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
245 more transactions on Pro →Context
Wall St
$157.13 avg target
-10.2% vs today · 24 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.45 act+$0.02
Q4 '25−$0.50 act−$0.03
Q3 '25−$0.39 act+$0.10
Q2 '25−$0.44 act+$0.07
Coverage
Here Are Tuesday’s Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More24/7 Wall St. · 06-023 Reasons GH is Risky and 1 Stock to Buy InsteadStockStory · 06-01Testing & Diagnostics Services Stocks Q1 Earnings: Guardant Health (NASDAQ:GH) Firing on All CylindersStockStory · 05-29
The file stays open
250 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice